Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Sutter

Showing results (141-150 of 179) with videos related to

Pageof 18
Sort By:
Emerging Infectious Diseases|May 20, 2015
Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccineRory D de Vries, Heidi L M De Gruyter, Theo M Bestebroer, et al.
The Journal of Infectious Diseases|November 18, 2008
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpoxNir Paran, Yasemin Suezer, Shlomo Lustig, et al.
Nature Communications|March 7, 2023
Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251Jeffy G Mattathil, Asisa Volz, Olusegun O Onabajo, et al.
International Journal of Molecular Sciences|October 26, 2024
Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept StudySatendra Kumar, Liangliang Nan, Georgia Kalodimou, et al.
Plos Neglected Tropical Diseases|September 5, 2014
Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challengePetra van den Doel, Asisa Volz, Jouke M Roose, et al.
JHEP Reports : Innovation in Hepatology|January 30, 2023
Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune toleranceJulia Sacherl, Anna D Kosinska, Kristina Kemter, et al.
Viruses|March 28, 2024
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge InfectionSabrina Clever, Leonard Limpinsel, Christian Meyer Zu Natrup, et al.
Plos Pathogens|February 6, 2020
Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infectionKatharina Borst, Sven Flindt, Patrick Blank, et al.
Journal of Virology|February 26, 2005
Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cellsGerald V Quinnan, Xiao-Fang Yu, Mark G Lewis, et al.
The Journal of Infectious Diseases|May 2, 2007
Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1Joost H C M Kreijtz, Yasemin Suezer, Geert van Amerongen, et al.
Pageof 18

Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
Emerging Infectious Diseases|May 20, 2015
Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccineRory D de Vries, Heidi L M De Gruyter, Theo M Bestebroer, et al.
The Journal of Infectious Diseases|November 18, 2008
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpoxNir Paran, Yasemin Suezer, Shlomo Lustig, et al.
Nature Communications|March 7, 2023
Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251Jeffy G Mattathil, Asisa Volz, Olusegun O Onabajo, et al.
International Journal of Molecular Sciences|October 26, 2024
Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept StudySatendra Kumar, Liangliang Nan, Georgia Kalodimou, et al.
Plos Neglected Tropical Diseases|September 5, 2014
Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challengePetra van den Doel, Asisa Volz, Jouke M Roose, et al.
JHEP Reports : Innovation in Hepatology|January 30, 2023
Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune toleranceJulia Sacherl, Anna D Kosinska, Kristina Kemter, et al.
Viruses|March 28, 2024
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge InfectionSabrina Clever, Leonard Limpinsel, Christian Meyer Zu Natrup, et al.
Plos Pathogens|February 6, 2020
Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infectionKatharina Borst, Sven Flindt, Patrick Blank, et al.
Journal of Virology|February 26, 2005
Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cellsGerald V Quinnan, Xiao-Fang Yu, Mark G Lewis, et al.
The Journal of Infectious Diseases|May 2, 2007
Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1Joost H C M Kreijtz, Yasemin Suezer, Geert van Amerongen, et al.
Pageof 18